BioLineRx Capital Expenditures (CapEx) Growth & History (BLRX)

BioLineRx's capital expenditures (capex) was $25,000 for fiscal 2025.

View full BioLineRx company overview

BioLineRx annual capital expenditures (capex) history

BioLineRx annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$25,000−$28,000−52.83%
20242024-12-31$53,000−$63,000−54.31%
20232023-12-31$116,000−$15,000−11.45%
20222022-12-31$131,000$34,000+35.05%
20212021-12-31$97,000$97,000
20202020-12-31$0−$67,000
20192019-12-31$67,000−$106,000−61.27%
20182018-12-31$173,000−$165,000−48.82%
20172017-12-31$338,000$286,000+550.00%
20162016-12-31$52,000−$2.6M−98.06%
20152015-12-31$2.7M

BioLineRx capital expenditures (capex) trends

Over the last five fiscal years, BioLineRx's capital expenditures (capex) increased from $0 to $25,000, a change of $25,000. The latest reported quarter, Q1 2026, shows $6,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review BioLineRx source filings ↗

Community posts

It’s quiet here.

No posts about BLRX yet. Start the conversation.

Write the first post